RAGE mediates vascular injury and inflammation after global cerebral ischemia

Neurochem Int. 2012 Feb;60(3):220-8. doi: 10.1016/j.neuint.2011.12.008. Epub 2011 Dec 19.

Abstract

The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor involved in a diverse range of pathological conditions. To analyze the roles of RAGE and its decoy receptor, endogenous secretory RAGE (esRAGE), in the global cerebral ischemia, three different mouse cohorts, wild-type, RAGE⁻/⁻, and esRAGE transgenic (Tg) mice were subjected to bilateral common carotid artery occlusion (BCCAO). RT-PCR and immunohistochemical analysis revealed that expression of RAGE was induced in the vascular cells at 12 h, and then in the neurons and glia from 3 to 7 days in the hippocampus after BCCAO. The numbers of surviving neurons in the hippocampal CA1 region were significantly higher in RAGE⁻/⁻ and esRAGE Tg mice than those in wild-type mice in the periods between 24 h and 7 days after BCCAO. Lower levels of 3-nitrotyrosine (3-NT) and higher levels of endothelial nitric oxide synthase (eNOS), together with enlarged vascular areas were observed in RAGE⁻/⁻ and esRAGE Tg mice at 12 h after BCCAO. In the later periods, expressions of glia-derived inflammatory mediators TNFα and inducible nitric oxide synthase (iNOS) were reduced in RAGE⁻/⁻ and esRAGE Tg mice. These results suggest that RAGE may contribute to delayed neuronal death after global cerebral ischemia by enhancing vascular injury and deleterious glia-mediated inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / pathology*
  • Carotid Artery Injuries / pathology
  • Cell Death / physiology
  • Image Processing, Computer-Assisted
  • Immunohistochemistry
  • Inflammation / pathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Neuroglia / physiology
  • Nitric Oxide Synthase Type II / biosynthesis
  • Nitric Oxide Synthase Type III / biosynthesis
  • Oxidative Stress / physiology
  • Real-Time Polymerase Chain Reaction
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / physiology*
  • Stroke / pathology*
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tyrosine / analogs & derivatives
  • Tyrosine / pharmacology
  • Vascular System Injuries / pathology*

Substances

  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
  • Tumor Necrosis Factor-alpha
  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III